SMTL ID : 7z78.2 (2 other biounits)

Crystal structure of compound 4 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.32 Å

Oligo State

monomer

Ligands

1 x IF8: 4-bromanyl-7-cyclopentyl-9-piperidin-4-yl-benzimidazolo[1,2-a]quinazolin-5-one(Non-covalent)

IF8.1: 16 residues within 4Å: Chain A: V.38, F.39, Q.41, L.42, P.43, E.47, L.48, Y.51, V.59, D.60, L.86, N.89, A.90, F.93, N.94, I.100 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.38, A:L.48, A:D.60, A:F.93, A:I.100 Hydrogen bonds: A:Y.51, A:N.94 pi-Stacking: A:F.39, A:Y.51 Halogen bonds: A:L.86

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 2 residues within 4Å: Chain A: R.69, H.71 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.71, H2O.1, H2O.1

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kofink, C. et al., A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo. Nat Commun (2022)

Release Date

2022-09-14

Peptides

Probable global transcription activator SNF2L2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Probable global transcription activator SNF2L2

Related Entries With Identical Sequence